FilingReader Intelligence

Hubei Jumpcan unit redeems RMB 17m in deposits

February 20, 2025 at 11:25 AM UTCBy FilingReader AI

Hubei Jumpcan Pharmaceutical Co., Ltd. (SSE:600566) announced that its wholly-owned subsidiary, Jichuan (Shanghai) Medical Technology Co., Ltd., has redeemed a structured deposit product with Bohai Bank, recovering the principal of RMB 17 million. The investment yielded a return of RMB 106,900, in line with expectations. This redemption is part of the company’s strategy to manage idle raised funds, with the total amount of cash management reaching RMB 56 million. The company has been approved to invest in cash management products up to RMB 580 million.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Hubei Jumpcan Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →